Clinical and therapeutic aspects of congenital and acquired long QT syndrome.
about
Long QT Syndrome: An Emerging Role for Inflammation and ImmunityCongenital long QT syndromes: clinical features, molecular genetics and genetic testing.Metastatic melanoma presenting as polymorphic ventricular tachycardia.Torsades de pointes following clarithromycin treatment.Drug-induced QT interval prolongation: mechanisms and clinical managementPrevention of Pazopanib-Induced Prolonged Cardiac Repolarization and Proarrhythmic EffectsA survey of health care practitioners' knowledge of the QT intervalProbable case of torsades de pointes induced by fluconazole.Inducibility of ventricular fibrillation during mild therapeutic hypothermia: electrophysiological study in a swine model.QTc prolongation assessment in anticancer drug development: clinical and methodological issuesMagnesium in disease.Age-and sex-dependent mRNA expression of KCNQ1 and HERG in patients with long QT syndrome type 1 and 2.Brugada and long QT-3 syndromes: two phenotypes of the sodium channel disease.Pharmacogenomics and acquired long QT syndrome.After more than 300 defibrillation shocks, patient still alive 12 years later refractory torsade de pointes due to polypharmacy and persistent vomitingIntravenous palonosetron increases the incidence of QTc prolongation during sevoflurane general anesthesia for laparotomy.QT prolongation in a child with thyroid storm.QT prolongation in the intensive care unit: commonly used medications and the impact of drug-drug interactions.QT interval prolongation in liver cirrhosis: innocent bystander or serious threat?Targeted cancer therapy: giving histone deacetylase inhibitors all they need to succeed.Short-term QT variability markers for the prediction of ventricular arrhythmias and sudden cardiac death: a systematic review.Pharmacogenomics and pharmacogenetics for the intensive care unit: a narrative review.Effect of beta-adrenoceptor blockers on human ether-a-go-go-related gene (HERG) potassium channels.Strategy for enhancing the therapeutic efficacy of histone deacetylase inhibitor dacinostat: the novel paradigm to tackle monotonous cancer chemoresistance.Is there a relation between SIDS and long QT syndrome?Torsade de Pointes after administration of droperidol for nausea and vomiting.Cardiac changes in horses with atypical myopathy.Mechanisms, risk factors, and management of acquired long QT syndrome: a comprehensive review.
P2860
Q26769710-8E7CEDA6-CC8B-4741-BB98-E716194E3A2AQ33153847-D85424F6-8618-4211-A030-3495FC9D368AQ33162231-DE21CC7F-23E1-4D58-A025-126AFDA66A96Q33163427-83FCD762-F5F7-4EE6-9F19-DE31B696ECBEQ33949538-C82230C2-88FF-43EF-A3AB-CFBF5FCD3E26Q34670026-99540359-AB4B-4F7A-816A-FE236F05FECCQ34723049-C60C4603-E640-417F-9C1B-0E29CABEF738Q35031661-F2F2C337-E89A-403E-ABDF-0A9A4E504E16Q35127757-7878F308-0789-4EF4-8385-56A132C11D56Q35572883-8C5AC49E-55C6-46FB-B6E3-036493963394Q35683765-C2E4876A-5A27-4234-9692-9A87667B262DQ35691352-CF2605A2-C26B-40C9-98BC-D1270880C2E6Q35831609-A691F48C-65B8-4A53-9F7F-BDE263F656ADQ36192679-6F057255-692E-4DC5-9EEF-DB88DC4D8AE0Q37055990-6639C5C2-697E-4B65-A7B1-6CC93E91D197Q37399666-98FD6C26-07C2-4911-9618-3EEF00A7BEC4Q37704166-42F767DB-0747-4A52-B06A-C222E737CF5AQ37727223-71AEB512-7CDD-4728-8941-E8F8207FC3E2Q37965681-E433D6ED-EE84-4F22-BB8C-FA877F2793EFQ37993589-1FA775AB-A4B1-4A34-AF69-6F190D1280B7Q38237048-CCB1FD8C-6959-4E15-B48D-A94C27F60E27Q38983589-57DFD036-5B9E-406E-AABD-8AF26C5CF0FDQ40464186-E7DEDE7D-CB51-4C3B-B4D6-739B32A412E1Q41203569-964B3926-5EFC-48E1-B5CA-D65F1779130CQ41789575-41D68440-1376-444F-A224-BE54C42ACA20Q46086026-95E36754-44B7-4CAA-871A-C09DD85AE3C0Q49161742-18B6320A-A09C-4C25-A3A8-67921DC31972Q55668871-87C17B27-8F1A-4971-A3DC-3032EBB3677A
P2860
Clinical and therapeutic aspects of congenital and acquired long QT syndrome.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
name
Clinical and therapeutic aspects of congenital and acquired long QT syndrome.
@ast
Clinical and therapeutic aspects of congenital and acquired long QT syndrome.
@en
type
label
Clinical and therapeutic aspects of congenital and acquired long QT syndrome.
@ast
Clinical and therapeutic aspects of congenital and acquired long QT syndrome.
@en
prefLabel
Clinical and therapeutic aspects of congenital and acquired long QT syndrome.
@ast
Clinical and therapeutic aspects of congenital and acquired long QT syndrome.
@en
P1476
Clinical and therapeutic aspects of congenital and acquired long QT syndrome.
@en
P2093
Ijaz A Khan
P356
10.1016/S0002-9343(01)01011-7
P407
P577
2002-01-01T00:00:00Z